Breaking News
December 12, 2018 - Regulating the immune system’s ‘regulator’
December 12, 2018 - In breaking bad news, the comfort of silence
December 12, 2018 - Study finds upward link between alcohol consumption and physical activity in college students
December 12, 2018 - FDA issues warning letter to Zhejiang Huahai Pharmaceutical involved in valsartan recall
December 12, 2018 - Presence of antiphospholipid antibodies tied to first-time MI
December 12, 2018 - New study could help inform research on preventing falls
December 12, 2018 - Women and men with heart attack symptoms receive different care from EMS
December 12, 2018 - Disrupted biological clock can contribute to onset of diseases, USC study shows
December 12, 2018 - New publications generate controversy over the value of reducing salt consumption in populations
December 12, 2018 - New data from TAILORx trial confirms lack of chemo benefit regardless of race or ethnicity
December 12, 2018 - Specific class of biomarkers can accurately indicate the severity of cancer
December 12, 2018 - Meds Taken Do Not Vary With ADL Impairment in Heart Failure
December 12, 2018 - Long-term study shows that HIV-2 is deadlier than previously thought
December 12, 2018 - People living near oil and gas wells show early signs of cardiovascular disease
December 12, 2018 - IONTAS founder and pioneer in phage display technology attends Nobel Prize Award Ceremony
December 12, 2018 - People who eat red meat have high levels of chemical associated with heart disease, study finds
December 12, 2018 - New method uses water molecules to unlock neurons’ secrets
December 12, 2018 - New computer model predicts prostate cancer progression
December 12, 2018 - Nobel Laureates lecture about immune checkpoint therapy for cancer treatment
December 12, 2018 - More Illnesses From Tainted Romaine Lettuce Reported
December 12, 2018 - Aspirin could reduce HIV infections in women
December 12, 2018 - The EORTC Brain Tumor Group and Protagen AG collaborate to study immuno-competence of long-term glioblastoma survivors
December 12, 2018 - Insights into magnetotactic bacteria could guide development of biological nanorobots
December 12, 2018 - Sacrificial immune cells alert body to infection
December 12, 2018 - Low-salt diet may be more beneficial for females than males
December 12, 2018 - Major soil organic matter compound battles chronic wasting disease
December 12, 2018 - Findings may open up new ways to treat dwarfism and other ER-stress-related conditions
December 12, 2018 - New computational model provides clearer picture of shape-changing cells’ structure and mechanics
December 12, 2018 - 10 Facts on Patient Safety
December 12, 2018 - Poorest dying nearly 10 years younger than the rich in ‘deeply worrying’ trend for UK
December 12, 2018 - Innovative care model for children with ASD reduces use of behavioral drugs in ED
December 12, 2018 - Spending time in and around Hong Kong’s waters linked to better health and wellbeing
December 12, 2018 - Simple measures to prevent weight gain over Christmas
December 12, 2018 - Research advances offer hope for patient-tailored AML treatment
December 12, 2018 - Researchers discover a ‘blind spot’ in atomic force microscopy
December 12, 2018 - Sprayable gel could help prevent recurrences of cancer after surgery
December 12, 2018 - SLU researchers explore how fetal exposure to inflammation can alter immunity in newborns
December 12, 2018 - How do patients want to discuss symptoms with clinicians?
December 12, 2018 - Zinc chelation may be able to deliver drug to insulin-producing cells
December 12, 2018 - Brigham researchers develop automated, low-cost tool to predict a woman’s ovulation
December 12, 2018 - Some people with Type 2 diabetes may be testing their blood sugar more often than needed
December 12, 2018 - Slow-growing type of glioma may be vulnerable to immunotherapy, suggests study
December 12, 2018 - Study provides new information regarding microRNA function in cellular homeostasis of zebrafish
December 12, 2018 - Study provides new understanding of mysterious ‘hereditary swelling’
December 12, 2018 - Researchers shed new light on how to combat Shiga and ricin toxins
December 12, 2018 - Pregnant Women Commonly Refuse Vaccines
December 12, 2018 - Drug treatment could offer new hope for some patients with brain bleeding
December 12, 2018 - Health care financial burden of animal-related injuries is growing, study says
December 12, 2018 - Macrophage cells could help repair the heart following a heart attack, study finds
December 12, 2018 - Researchers develop new system for efficiently producing human norovirus
December 12, 2018 - New artificial intelligence-based system to differentiate between different types of cancer cells
December 11, 2018 - Brazilian professors propose guidelines for therapeutic use of melatonin
December 11, 2018 - Healthy Lifestyle Lowers Odds of Breast Cancer’s Return
December 11, 2018 - New research identifies two genes linked to serious congenital heart condition
December 11, 2018 - NIH Director talks science, STEM careers with preteens
December 11, 2018 - Disabling a Cellular Antivirus System Could Improve Gene Therapy
December 11, 2018 - New tool swiftly provides accurate measure of patients’ cognitive difficulties
December 11, 2018 - NICE releases new guidelines for diagnosis and management of COPD
December 11, 2018 - Without Obamacare penalty, think it’ll be nice to drop your plan? Better think twice
December 11, 2018 - Researchers capture high-resolution X-ray and NMR image of key immune regulator
December 11, 2018 - Natural flavonoid is effective at treating leishmanisis infections, study shows
December 11, 2018 - Avoidant grievers unconsciously monitor and block mind-wandering contents, study shows
December 11, 2018 - Study identifies how hantaviruses infect lung cells
December 11, 2018 - Improving PTSD care through genetics
December 11, 2018 - Dermatology providers show interest in recommending cannabinoids to patients
December 11, 2018 - Researchers to study effects of electroconvulsive therapy on Alzheimer’s patients with aggression
December 11, 2018 - Four dried fruits have lower glycemic index than starchy foods, study finds
December 11, 2018 - Optimization of drug dose sizes can reduce pharmaceutical wastage
December 11, 2018 - Ultrarestrictive opioid prescribing strategy linked with reduction in number of pills dispensed
December 11, 2018 - PET scans to optimize tuberculosis meningitis treatments and personalize care, study finds
December 11, 2018 - Researchers aim to identify and target high blood pressure indicators
December 11, 2018 - Researchers identify immune cell subset that may drive chronic inflammation
December 11, 2018 - Ezogabine treatment reduces motor neuron excitability in ALS patients, study shows
December 11, 2018 - One implant, two prices. It depends on who’s paying.
December 11, 2018 - Standardizing feeding practices improves growth trends for micro-preemies
December 11, 2018 - COPD Tied to Obesity in Male, Female Never-Smokers
December 11, 2018 - Flossing: Information for Caregivers
December 11, 2018 - Does breastfeeding hormone protect against type 2 diabetes?
December 11, 2018 - Educating future doctors to prescribe physical activity for their patients
December 11, 2018 - Krystal 2000 microplate design improves fluorescence and luminescence measurement
A novel drug delivery system for controlled release of aspirin

A novel drug delivery system for controlled release of aspirin

image_pdfDownload PDFimage_print
Credit: Dasgupta et al.

An interdisciplinary team of researchers at the Indian Institute of Science has designed a novel chemical compound that can be tailored to release aspirin over a desired duration inside the body. It also has several advantages over existing mechanisms: It is harmless to living cells, can carry a large amount of the drug, and can easily be injected.

Commonly used pills or patches have aspirin trapped inside a capsule or a mesh. The new compound, however, has aspirin built directly into the backbone of a long polymer chain with a sugar molecule called xylitol as the base. Xylitol is naturally found in fruits and vegetables, and used as a sweetener. As the bond between xylitol and the drug is slowly broken down by the body’s enzymes, the drug will gradually diffuse into the bloodstream.

“Unlike pills that release all the drug at the same time, this would allow the molecule to circulate longer and have a more prolonged effect,” says Kaushik Chatterjee, one of the authors of the paper published in the International Journal of Pharmaceutics.

Aspirin is best known for reducing fever and pain. This household drug can also lower the risk of heart attack or stroke by preventing clots from forming in blood vessels. Previous research has shown that a gradual release of aspirin instead of a rapid initial burst can stave off unwanted side effects. A single compound that circulates in the body and releases a certain amount of aspirin periodically may also provide an alternative to taking multiple pills at different times.

In recent years, scientists have turned to polymers—large molecules with repeating units—to develop slow-release systems with the drug built in. Ideally, such a compound should also be harmless to living cells and be able to carry a large amount of drug.

In this study, the researchers picked a sugar alcohol called xylitol as its base because it meets all the above requirements. For one, it forms degradable polymers that can break down slowly inside the body, giving the drug a longer time to diffuse. It also has more free sites for the drug to bind than other alcohols.

“Another major advantage is that it is entirely biodegradable,” says first author Queeny Dasgupta, PhD student at the Centre for Biosystems Science and Engineering. “All the precursors used to make the polymer are endogenous (native) to the body so there is no accumulation.” Xylitol is also relatively unreactive and unlikely to interfere with aspirin’s action.

However, previously developed xylitol-based polymers have a drawback. During synthesis, they form complex mesh-like structures (crosslinked polymers) that are difficult to dissolve and inject, and have to be surgically implanted inside the body.

In the current study, the researchers modified the reaction conditions in such a way that xylitol was forced to form a long, straight chain that can easily be dissolved into a gel and injected. “The linear chain is important because only then can you inject it. Once it forms a network, it becomes a solid lump that is implantable but not injectable,” says Chatterjee. The linear polymerization was achieved using a novel technique.

The researchers found that their compound was able to release about 8% of the drug in the first week, 13% in the second and 20% by four weeks. When tested with blood cells in the lab, the released drug was able to reduce inflammation—a key reaction in reducing pain—as expected.

By tweaking the type of chemical bonds and number of free sites that the compound has, the timing and dose of drug delivery can be adjusted, the authors say. “For example, if you want low doses of aspirin over sustained periods, say weeks, then you may want to have more such bonds that would not degrade so easily,” says Chatterjee.

The technique can also be used to develop similar delivery vehicles for other drugs with sustained and tunable release, the researchers say.


Explore further:
Good and bad news on aspirin and colon cancer: study

More information:
Controlled release from aspirin based linear biodegradable poly(anhydride esters) for anti-inflammatory activity, International Journal of Pharmaceutics, August 2017. www.sciencedirect.com/science/ … ii/S0378517317305732

Provided by:
Indian Institute of Science

Tagged with:

About author

Related Articles